Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 762.1
(0.67%)
INR 762.1
(0.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.04 Billion INR | 24.88% |
| 2022 | 835.99 Million INR | 42.37% |
| 2021 | 587.2 Million INR | 51.95% |
| 2020 | 386.45 Million INR | 4.23% |
| 2019 | 370.79 Million INR | 48.67% |
| 2018 | 249.4 Million INR | 123.02% |
| 2017 | 111.83 Million INR | -36.64% |
| 2016 | 176.51 Million INR | 24.76% |
| 2015 | 141.47 Million INR | 66.54% |
| 2014 | 84.95 Million INR | 27.32% |
| 2013 | 66.72 Million INR | 49.4% |
| 2012 | 44.66 Million INR | -1.13% |
| 2011 | 45.17 Million INR | 26.74% |
| 2010 | 35.64 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 21.58 Million INR | -97.93% |
| 2023 Q1 | 37.43 Million INR | -95.52% |
| 2023 Q3 | 1.04 Billion INR | 64.43% |
| 2023 FY | 1.04 Billion INR | 24.88% |
| 2023 Q2 | 633.46 Million INR | 1592.35% |
| 2023 Q4 | 1.04 Billion INR | 0.23% |
| 2022 Q3 | 2.86 Million INR | -99.66% |
| 2022 FY | 835.99 Million INR | 42.37% |
| 2022 Q4 | 835.99 Million INR | 29039.04% |
| 2022 Q2 | 848.3 Million INR | 3883.03% |
| 2022 Q1 | 21.29 Million INR | -96.37% |
| 2021 Q1 | 11.86 Million INR | -96.93% |
| 2021 FY | 587.2 Million INR | 51.95% |
| 2021 Q2 | 454.22 Million INR | 3729.37% |
| 2021 Q3 | 6.04 Million INR | -98.67% |
| 2021 Q4 | 587.2 Million INR | 9621.99% |
| 2020 Q1 | 30.94 Million INR | -91.66% |
| 2020 FY | 386.45 Million INR | 4.23% |
| 2020 Q3 | 22.11 Million INR | -86.41% |
| 2020 Q2 | 162.78 Million INR | 426.1% |
| 2020 Q4 | 386.45 Million INR | 1647.49% |
| 2019 Q2 | 266.64 Million INR | 1665.94% |
| 2019 Q1 | 15.09 Million INR | -93.95% |
| 2019 FY | 370.79 Million INR | 48.67% |
| 2019 Q4 | 370.79 Million INR | 2275.03% |
| 2019 Q3 | 15.61 Million INR | -94.14% |
| 2018 FY | 249.4 Million INR | 123.02% |
| 2018 Q3 | 20.69 Million INR | -89.17% |
| 2018 Q2 | 191.01 Million INR | 0.0% |
| 2018 Q4 | 249.4 Million INR | 1105.18% |
| 2017 Q4 | 85.32 Million INR | 0.0% |
| 2017 FY | 111.83 Million INR | -36.64% |
| 2017 Q2 | 123.93 Million INR | 1551.41% |
| 2017 Q1 | 7.5 Million INR | -94.67% |
| 2016 Q3 | 16.36 Million INR | -90.26% |
| 2016 Q2 | 168.04 Million INR | 0.0% |
| 2016 FY | 176.51 Million INR | 24.76% |
| 2016 Q4 | 140.71 Million INR | 759.77% |
| 2015 Q4 | 141.47 Million INR | 2350.23% |
| 2015 Q1 | 6.01 Million INR | -92.92% |
| 2015 Q2 | 111.18 Million INR | 1747.81% |
| 2015 FY | 141.47 Million INR | 66.54% |
| 2015 Q3 | 5.77 Million INR | -94.81% |
| 2014 FY | 84.95 Million INR | 27.32% |
| 2014 Q3 | 11.09 Million INR | -82.9% |
| 2014 Q2 | 64.92 Million INR | 1453.7% |
| 2014 Q4 | 84.95 Million INR | 665.4% |
| 2014 Q1 | 4.17 Million INR | -93.74% |
| 2013 Q3 | 4.77 Million INR | -90.99% |
| 2013 Q4 | 66.72 Million INR | 1298.27% |
| 2013 Q2 | 52.94 Million INR | 0.0% |
| 2013 FY | 66.72 Million INR | 49.4% |
| 2012 FY | 44.66 Million INR | -1.13% |
| 2012 Q4 | 44.66 Million INR | 0.0% |
| 2011 FY | 45.17 Million INR | 26.74% |
| 2010 FY | 35.64 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | -4040.685% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | -141.821% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 2439.559% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 1470.931% |
| Sunil Healthcare Limited | 625.4 Million INR | -66.933% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 17333.493% |
| MedPlus Health Services Limited | 8.67 Billion INR | 87.971% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | -51.439% |
| Patidar Buildcon Limited | 25.12 Million INR | -4055.078% |
| Roopa Industries Limited | 216.01 Million INR | -383.302% |
| Smruthi Organics Limited | 111.28 Million INR | -838.103% |
| Trident Lifeline Limited | 117.56 Million INR | -788.061% |
| PANJON LTD. | -12.8 Million INR | 8251.195% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -2699.842% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -2664.551% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -7665.006% |
| Anuh Pharma Limited | -69.8 Million INR | 1595.559% |
| Crestchem Limited | -1.45 Million INR | 72100.345% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 1819.036% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 9233.902% |
| Tyche Industries Limited | -788.94 Million INR | 232.33% |
| Trimurthi Limited | -1.17 Million INR | 88710.168% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 1629.342% |
| Norris Medicines Limited | 214.86 Million INR | -385.897% |
| Zenlabs Ethica Limited | 139.54 Million INR | -648.144% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -2602.926% |
| ANG Lifesciences India Limited | 671.01 Million INR | -55.586% |
| Parmax Pharma Limited | 51.8 Million INR | -1915.068% |
| Veerhealth Care Limited | -2.38 Million INR | 43873.795% |
| Deccan Health Care Limited | -7.07 Million INR | 14854.169% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 0.28% |
| Makers Laboratories Limited | 172.59 Million INR | -504.901% |
| Lactose (India) Limited | 373.97 Million INR | -179.167% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | -82.733% |
| Zenith Healthcare Limited | -25.45 Million INR | 4201.053% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 1314.666% |
| Bacil Pharma Limited | 569 Thousand INR | -183380.668% |
| PRAVEG LIMITED | -434.98 Million INR | 340.008% |
| Denis Chem Lab Limited | -236.28 Million INR | 541.841% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | -13.263% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 231.833% |
| Colinz Laboratories Limited | -64.3 Million INR | 1723.571% |
| Godavari Drugs Limited | 530.02 Million INR | -96.975% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 11313.802% |
| Zenotech Laboratories Limited | -196.85 Million INR | 630.337% |
| Panchsheel Organics Limited | -157.82 Million INR | 761.512% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -417.2% |
| Vivanza Biosciences Limited | 50.02 Million INR | -1986.925% |
| Phaarmasia Limited | -4.89 Million INR | 21419.277% |
| Sastasundar Ventures Limited | -297.24 Million INR | 451.222% |
| Medi-Caps Limited | -3.21 Million INR | 32583.043% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 1220.923% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 2037.505% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -690.314% |
| Mercury Laboratories Limited | -26.72 Million INR | 4005.889% |
| Gennex Laboratories Limited | -552.54 Million INR | 288.945% |
| BDH Industries Limited | -164.47 Million INR | 734.769% |
| Coral Laboratories Limited | -612.82 Million INR | 270.359% |
| Concord Drugs Limited | 164.48 Million INR | -534.704% |
| Bharat Parenterals Limited | 1.48 Billion INR | 29.872% |
| Beryl Drugs Limited | 48.7 Million INR | -2043.395% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -1226.495% |
| Evoq Remedies Limited | 41.14 Million INR | -2437.195% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -798.084% |
| Transchem Limited | -3.16 Million INR | 33106.797% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 2270.579% |
| Parnax Lab Limited | 787.61 Million INR | -32.552% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 1882.004% |
| Kerala Ayurveda Limited | 447.82 Million INR | -133.126% |
| Cian Healthcare Limited | 544.97 Million INR | -91.57% |
| Trinity League India Limited | -12 Thousand INR | 8700141.658% |
| Syschem (India) Limited | 3.53 Million INR | -29458.465% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 25.167% |
| Natural Capsules Limited | 956.68 Million INR | -9.128% |
| Auro Laboratories Limited | 252.51 Million INR | -313.441% |